Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Screeners that run automatically... and then email you the results! FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Loxo Oncology CS (LOXO)

Loxo Oncology CS (LOXO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,182,943
  • Shares Outstanding, K 30,615
  • Annual Sales, $ 21,300 K
  • Annual Income, $ -148,880 K
  • 60-Month Beta 2.51
  • Price/Sales 49.61
  • Price/Cash Flow N/A
  • Price/Book 18.85
Trade LOXO with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.09
  • Most Recent Earnings -0.89 on 11/08/18
  • Next Earnings Date 03/07/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate -1.16
  • Number of Estimates 8
  • High Estimate -0.56
  • Low Estimate -2.47
  • Prior Year -0.69
  • Growth Rate Est. (year over year) -68.12%

Price Performance

See More
Period Period Low Period High Performance
1-Month
233.14 +0.71%
on 01/16/19
234.93 -0.06%
on 02/13/19
+1.13 (+0.48%)
since 01/15/19
3-Month
125.00 +87.84%
on 12/24/18
234.93 -0.06%
on 02/13/19
+83.27 (+54.95%)
since 11/15/18
52-Week
103.50 +126.86%
on 02/20/18
234.93 -0.06%
on 02/13/19
+129.83 (+123.68%)
since 02/15/18

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Loxo Oncology, Inc. is a biopharmaceutical company. It develops targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Loxo Oncology, Inc. is headquartered in Stamford, Connecticut.

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 234.95
1st Resistance Point 234.81
Last Price 234.80
1st Support Level 234.59
2nd Support Level 234.51
3rd Support Level N/A

See More

52-Week High 234.93
Last Price 234.80
Fibonacci 61.8% 184.72
Fibonacci 50% 169.21
Fibonacci 38.2% 153.71
52-Week Low 103.50

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar